Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Histone modification is key in treating chronic inflammatory skin diseases.

Topical JAK inhibitors may help treat some skin conditions but need more research.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Different hair loss types need accurate diagnosis for proper treatment.

Vitamin D is crucial for health, and deficiency can cause hair loss and other health issues.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.